Radiopharm Theranostics (RADX)

• Market cap: $40.9M
• 1 day: -5.46%
• 5 days: -62.69%
• 1 month: 12.34%
• 3 months: -20.03%
• 6 months: 15.08%
• Year to date: 11.85%
• 1 year: 16.37%
• 5 years: -70.63%
• 10 years: -70.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14